<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00310765</url>
  </required_header>
  <id_info>
    <org_study_id>3727</org_study_id>
    <nct_id>NCT00310765</nct_id>
  </id_info>
  <brief_title>Pregabalin for Abdominal Pain From Adhesions</brief_title>
  <official_title>Pregabalin for the Treatment of Abdominal Pain From Adhesions: Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henry Ford Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Henry Ford Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate if pregabalin demonstrates significant reduction in
      abdominal pain from adhesions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be prospective, double-blinded and randomized. The study will run for 12
      weeks. During the first 7 weeks there will be 2 groups in the study with subjects receiving a
      placebo or the study drug. During the last 4 weeks of the study, all subjects will be offered
      the study medication, pregabalin. The primary outcome measure will be pain relief documented
      by a 2-point change on the Likert pain scale with a secondary pain measure of sleep
      interruption.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study was terminated by the sponsor due to low accrual.
  </why_stopped>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in abdominal pain.</measure>
    <time_frame>7 weeks</time_frame>
    <description>Pain reduction as measured on a Likert scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improved sleep scores</measure>
    <time_frame>7 weeks</time_frame>
    <description>Improvement in Sleep by assessing Mean Daily sleep interference scores</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Abdominal Pain</condition>
  <condition>Surgical Adhesions</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>75-150 mg of pregabalin po BID</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo 75 or 150 mg po BID</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>First 7 weeks 75 or 150 mg of pregabalin po BID. Start at 75 mg and increase to 150 mg po BID if no improvement after 3 days</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <other_name>Look alike placebo 75 mg po BID. Increase to 150 mg if no improvement after 3 days.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>75 mg po BID</description>
    <arm_group_label>2</arm_group_label>
    <other_name>gabapentin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must have history of prior surgery and documented adhesions during laparoscopy or open
             laparotomy within 5 years

          -  Must have undergone an evaluation to exclude other causes of abdominal pain

          -  Abdominal pain must be present for greater than three months duration

        Exclusion Criteria:

          -  Patients that are pregnant or breast feeding

          -  Prior treatment with gabapentin, pregabalin or demonstrated sensitivity to these drugs

          -  Patients who are immunocompromised

          -  Patients with significant hepatic or renal insufficiency, or any significant
             hematologic disorder

          -  History of illicit alcohol or drug abuse within one year

          -  Documented serious or unstable medical or psychological condition

          -  Malignancy within the past 5 years other than in situ squamous cell carcinoma of the
             skin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ann L Silverman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Henry Ford Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>West Bloomfield</city>
        <state>Michigan</state>
        <zip>48322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Silverman A, Samuels Q, Gikas H, Nawras A. Pregabalin for the treatment of abdominal adhesion pain: a randomized, double-blind, placebo-controlled trial. Am J Ther. 2012 Nov;19(6):419-28. doi: 10.1097/MJT.0b013e318217a5f5.</citation>
    <PMID>22020082</PMID>
  </results_reference>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2006</study_first_submitted>
  <study_first_submitted_qc>March 31, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2006</study_first_posted>
  <last_update_submitted>September 4, 2012</last_update_submitted>
  <last_update_submitted_qc>September 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Henry Ford Health System</investigator_affiliation>
    <investigator_full_name>Ann L. Silverman</investigator_full_name>
    <investigator_title>DIRECTOR OF GI RESEARCH</investigator_title>
  </responsible_party>
  <keyword>abdominal pain</keyword>
  <keyword>surgical adhesions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Adhesions</mesh_term>
    <mesh_term>Abdominal Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

